Page results
-
The UCLH immunotherapy-neurotoxicity multidisciplinary service (IO-neurotox MDT) was established collaboratively between the National Hospital for Neurology and Neurosurgery (NHNN) and a nationwide oncology clinical team to offer high-quality diagnostic and management guidance on the care of cancer patients with, or suspected of having, any form of neurological complication of immunotherapy (immune-checkpoint inhibitor therapy).
-
This information aims to support and supplement the information provided in the Be Active video available on uclh.nhs.uk/wellbeing
-
Health and wellbeing information for people affected by cancer.
-
NBA Legend Isiah Thomas visited young basketball fans in the University College Hospital Macmillan Cancer Centre to chat with patients and staff, sign autographs and take selfies.
-
This information explains when planned caesareans would be provided at The Whittington Hospital for women having antenatal care at UCLH.
-
UCLH vision, values and strategy
-
Once again, UCLH has received the highest score of all general acute and acute/community NHS trusts in England for staff that would recommend us as a place to work
-
Our annual members' meeting (AMM) brings together members, governors and staff, and is where our governors officially receive our annual report and accounts.
-
Patient information on managing pain
-
Events, classes and workshops at the Macmillan Support and Information Service (MSIS)
File results
-
FOI/2024/0078 - Locally employed doctors at Trust
-
FOI/2024/0079 - Water procurement
-
FOI/2024/0080 - Patient treatment for botched non-surgical procedures
-
FOI/2024/0094 - Record Freedom of Information data 2023
-
FOI/2024/0095 - Hospital at home - Discharge and discharge to assess pathways
-
FOI/2024/0096 - Waiting lists for gynaecology treatment 2021-2024
-
FOI/2024/0097 - Laboratory Information Management System (LIMS)/ pathology IT system
-
FOI/2024/0101 - Immunoglobulin drug treatments
-
FOI/2024/0108 - Clinical letters/ EPR, PAS, patient portal systems, hybrid mail contract
-
FOI/2024/0112 - Fertility treatment in 2021